Benzinga | Nov 3, 2021 09:20AM EDT

RBC Capital Maintains Sector Perform on Amgen, Lowers Price Target to $216

RBC Capital analyst Kennen MacKay maintains Amgen (NASDAQ:AMGN) with a Sector Perform and lowers the price target from $217 to $216.